---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-183075"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2025-08-19T23:59:59+00:00"
generated_at: "2026-05-17T11:28:04.761577+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Evolent prices upsized $145M convertible notes at 4.50%; uses proceeds to repurchase 2025 notes and common stock.

## Summary
- Priced $145M (upsized from $140M) of 4.50% convertible senior notes due 2031; initial purchasers have 30-day option for additional $21.75M.
- Conversion price ~$13.53/share, representing ~50% premium over $9.02 closing price on Aug 18, 2025.
- Net proceeds estimated at $140.2M ($161.2M if option fully exercised), after fees and expenses.
- Approximately $100.2M plus available liquidity to repurchase ~$167.4M of existing 1.50% 2025 notes; ~$40M to repurchase 4.43M common shares at $9.02/sh.
- CFO states transaction avoids over $9M annual interest vs. credit facilities and extends next debt maturity to 2029.

## SEC filing metadata
- accession: 0001193125-25-183075
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2025-08-19T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000119312525183075/0001193125-25-183075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000119312525183075/d30469d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-183075
- JSON: https://secwatch.observer/filing/0001193125-25-183075.json
- Plain text: https://secwatch.observer/filing/0001193125-25-183075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.